Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?
about
Review article: the treatment of functional abdominal bloating and distension.Serotonin transporter gene polymorphism may be associated with functional dyspepsia in a Japanese population.Serotonin: a mediator of the brain-gut connection.Treatment of irritable bowel syndrome: a review of randomised controlled trials.A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea.Dyspepsia: management guidelines for the millennium.An antiemetic for irritable bowel syndrome?Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndromePharmacology of serotonin: what a clinician should know.Effects of the 5-HT3 antagonist cilansetron vs placebo on phasic sigmoid colonic motility in healthy man: a double-blind crossover trialEfficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trialsSystematic review: the efficacy of treatments for irritable bowel syndrome--a European perspective.Mechanisms of serotonergic agents for treatment of gastrointestinal motility and functional bowel disorders.A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia.Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist.[New drugs for the treatment of functional dyspepsia]Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome.Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron.Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome.Management of uninvestigated and functional dyspepsia: a working party report for the World Congresses of Gastroenterology 1998
P2860
Q33450132-515FD91D-9128-4B55-BA3E-4CDEFF0F3AE8Q33945867-3F5D2CC5-9E21-484B-A628-18598C8429A4Q34070408-6CFBDF1F-29F5-499F-AF88-1D93EB5F74E0Q34130605-05BE13EC-9411-4254-A826-644E9CC390A1Q34237231-462462B9-2663-4188-8600-39886EE00677Q34601100-843C625F-39CB-4B43-B4B7-5381B59D9297Q34854740-C9E7B510-544C-40D3-B5CA-9024FA07FE41Q35362266-33599112-1001-46C2-A8C7-EDA17276BACAQ35596862-EFBCD11D-2275-490D-9D67-F6533700857CQ36055161-BDC29619-E5A1-401E-912C-C7B337FA0685Q36307366-A671FF3F-1EB2-4B50-9D0A-F9FBD89DC4FFQ36536707-7FE66D46-205E-4CBD-8C09-1532EC4E9902Q36874388-A0A75095-4CA9-4AC2-BFE3-4927209B9D20Q39420214-654E47E4-FE58-4413-A865-0A39E1A1FD9DQ39436676-B19F4A91-DEF1-4323-8597-38FF0F2816A2Q43935948-7DD9FE3E-CB45-4909-816B-3F33AB283C0DQ44520650-F237E777-384B-4160-A172-B53FDCFB60C3Q46921547-B69D7DD7-D6EA-4D70-A953-FEA29CED4BB9Q53755018-0D2A2F94-C8F9-4105-A8AB-3A4E45B432F8Q57789860-74FF9FA8-D93E-4C11-AEB3-FB844B68AA48
P2860
Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Selective 5-hydroxytryptamine ...... rome and functional dyspepsia?
@ast
Selective 5-hydroxytryptamine ...... rome and functional dyspepsia?
@en
type
label
Selective 5-hydroxytryptamine ...... rome and functional dyspepsia?
@ast
Selective 5-hydroxytryptamine ...... rome and functional dyspepsia?
@en
prefLabel
Selective 5-hydroxytryptamine ...... rome and functional dyspepsia?
@ast
Selective 5-hydroxytryptamine ...... rome and functional dyspepsia?
@en
P2093
P1476
Selective 5-hydroxytryptamine ...... rome and functional dyspepsia?
@en
P2093
P304
P356
10.1046/J.1365-2036.1996.30172000.X
P407
P577
1996-08-01T00:00:00Z